Aurora Cannabis Inc. (TSE:ACB) to Post FY2027 Earnings of $0.03 Per Share, Atb Cap Markets Forecasts

Aurora Cannabis Inc. (TSE:ACBFree Report) – Analysts at Atb Cap Markets issued their FY2027 earnings per share estimates for Aurora Cannabis in a report released on Thursday, June 20th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings per share of $0.03 for the year. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ FY2028 earnings at $0.47 EPS and FY2029 earnings at $1.52 EPS.

A number of other research analysts have also recently commented on the company. Jefferies Financial Group decreased their price target on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. ATB Capital decreased their price target on Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating on the stock in a research report on Friday.

Read Our Latest Research Report on ACB

Aurora Cannabis Stock Down 0.9 %

Shares of TSE ACB opened at C$6.97 on Monday. The company has a debt-to-equity ratio of 18.51, a quick ratio of 2.48 and a current ratio of 3.79. Aurora Cannabis has a 52 week low of C$3.84 and a 52 week high of C$15.50. The stock has a market capitalization of C$380.14 million, a P/E ratio of -0.09 and a beta of 2.65. The stock’s fifty day moving average is C$8.83 and its 200 day moving average is C$4.96.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

See Also

Earnings History and Estimates for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.